HIV疫苗：应对病毒多样性的嵌合方法。 - Suppr

Suppr

超能文献

HIV vaccines: mosaic approach to virus diversity.

作者信息

Corey Lawrence, McElrath M Juliana

机构信息

Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

出版信息

Nat Med. 2010 Mar;16(3):268-70. doi: 10.1038/nm0310-268.

DOI:10.1038/nm0310-268

PMID:20208511

Abstract

摘要

相似文献

HIV vaccines: mosaic approach to virus diversity.

Nat Med. 2010 Mar;16(3):268-70. doi: 10.1038/nm0310-268.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Nat Med. 2010 Mar;16(3):324-8. doi: 10.1038/nm.2108. Epub 2010 Feb 21.

Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.

J Virol. 2006 Jul;80(14):6745-56. doi: 10.1128/JVI.02484-05.

Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination.

J Virol. 2009 Mar;83(5):2201-15. doi: 10.1128/JVI.02256-08. Epub 2008 Dec 24.

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.

J Infect Dis. 2016 Feb 15;213(4):541-50. doi: 10.1093/infdis/jiv496. Epub 2015 Oct 15.

Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.

J Hum Virol. 2001 Nov-Dec;4(6):306-16.

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

Nat Med. 2007 Jan;13(1):100-6. doi: 10.1038/nm1461. Epub 2006 Dec 24.

CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1.

Dokl Biochem Biophys. 2007 Mar-Apr;413:65-7. doi: 10.1134/s160767290702007x.

The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.

Vaccine. 2016 Apr 4;34(15):1744-51. doi: 10.1016/j.vaccine.2016.02.059. Epub 2016 Mar 3.

引用本文的文献

Quantifying prevalence and risk factors of HIV multiple infection in Uganda from population-based deep-sequence data.

PLoS Pathog. 2025 Apr 22;21(4):e1013065. doi: 10.1371/journal.ppat.1013065. eCollection 2025 Apr.

Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile.

Vaccines (Basel). 2025 Jan 28;13(2):135. doi: 10.3390/vaccines13020135.

Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine.

Toxins (Basel). 2022 Feb 14;14(2):138. doi: 10.3390/toxins14020138.

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.

Elife. 2021 Nov 23;10:e70330. doi: 10.7554/eLife.70330.

Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.

J Virol. 2015 Jun;89(12):6462-80. doi: 10.1128/JVI.00383-15. Epub 2015 Apr 8.

Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects.

J Virol. 2013 Sep;87(18):10004-15. doi: 10.1128/JVI.00359-13. Epub 2013 Jul 3.

For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

J Virol. 2012 Jan;86(2):1166-80. doi: 10.1128/JVI.05721-11. Epub 2011 Nov 9.

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11181-6. doi: 10.1073/pnas.1103012108. Epub 2011 Jun 20.

Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.

J Immunol. 2011 Jun 15;186(12):6914-24. doi: 10.4049/jimmunol.1004231. Epub 2011 May 16.

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

AIDS. 2011 Mar 13;25(5):679-89. doi: 10.1097/QAD.0b013e328342ff93.

本文引用的文献

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Nat Med. 2010 Mar;16(3):324-8. doi: 10.1038/nm.2108. Epub 2010 Feb 21.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

J Virol. 2009 Oct;83(20):10821-9. doi: 10.1128/JVI.00839-09. Epub 2009 Aug 12.

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

J Exp Med. 2009 Jun 8;206(6):1253-72. doi: 10.1084/jem.20090365. Epub 2009 Jun 1.

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Lancet. 2008 Nov 29;372(9653):1881-1893. doi: 10.1016/S0140-6736(08)61591-3. Epub 2008 Nov 13.

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Lancet. 2008 Jun 21;371(9630):2109-19. doi: 10.1016/S0140-6736(08)60920-4.

HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features.

Curr HIV Res. 2007 Jan;5(1):97-107. doi: 10.2174/157016207779316260.

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

Nat Med. 2007 Jan;13(1):100-6. doi: 10.1038/nm1461. Epub 2006 Dec 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验